Pharmacovigilance and adverse drug reactions medicine-based drug treatment individualization in oncology
Clinical trials and cognitive perspectives related to pharmacological options for the treatment of acute myeloid leukaemia.
Clinical data management and pharmacological considerations in intense lymphoblastic leukaemia patients.
Scientific progresses and hones of chemotherapy resistance and drug technology in tongue cancers.
An expressive note on biomarkers to create pharmacotherapy improvement and mutation drug resistance